Mount Desert Island Biological Lab’s scientists: Kevin Strange, Voot Yin and their collaborator Michael Zasloff have been awarded a patent for MSI-1436, a potential new heart disease drug that stimulates the repair and regeneration of heart tissue damaged by injuries like a heart attack, according to MaineBiz. This is the first patent for the lab. Prof. Kevin Strange, MDIBL’s president says: “The importance of this achievement cannot be overstated. This patent is a critical step forward in our ability to develop new treatments for those who suffer from heart disease (…)”. Read full story
Related Posts
Portland startup Marin Skincare launches lobster-based lip treatment
Portland startup Marin Skincare, known for its “lobster lotion,” is expanding that product line to include lip treatments. Founded out of the University...
UMaine scientists use eDNA to enhance river herring recovery research in Penobscot River
University of Maine researchers are seeking to gain more insight into river herring recovery in the Penobscot River using a novel...
FocusMaine co-founder named group’s next president
Nearly a decade after Andrea Cianchette Maker joined forces with Michael Dubyak to launch FocusMaine, Maker will lead the organization as...